{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:19:11Z","timestamp":1787318351763,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,10]]},"abstract":"<jats:p>\n                    Non-obese nonalcoholic fatty liver disease (NAFLD) is characterized by metabolic disorders and related complications. This study aimed to provide an integrated description of clinical, metabolic, and influencing factors for a specific category of patients with non-obese NAFLD. A total of 36 participants with body mass index (BMI) &lt; 28\u2009kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    and visceral adipose tissue &lt; 100\u2009cm\n                    <jats:sup>2<\/jats:sup>\n                    were classified into 2 groups: the non-obese, non-centrally obese control group (n = 17) and non-obese, non-centrally obese NAFLD group (n = 19). Hypertriglyceridemia, impaired fasting glucose, low high-density lipoprotein cholesterol levels, and hypertension were used to determine whether participants were metabolically abnormal. Based on a logistic regression model, odds ratios for the factors influencing NAFLD with 95% confidence intervals were calculated. Insulin resistance (IR) and fasting plasma glucose (FPG) levels were higher in the NAFLD group than in the control group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .05). The NAFLD group had a higher metabolic abnormality rate than the healthy control group (36.84% vs 5.88%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .044). Correlation analysis showed that IR was positively correlated with FPG and triglyceride (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .05). BMI was the main influencing factor of NAFLD (regression coefficient\n                    <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                    = 0.631; odds ratio = 1.879; 95% confidence interval, 1.233\u20132.863). NAFLD patients with a BMI &lt; 28\u2009kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    and visceral adipose tissue &lt; 100\u2009cm\n                    <jats:sup>2<\/jats:sup>\n                    had more apparent IR, higher FPG, and a higher metabolic abnormality rate. IR may be affected by FPG and triglyceride. Even in non-obese and non-centrally obese individuals, BMI should be controlled to avoid NAFLD.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000032922","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T11:18:30Z","timestamp":1676027910000},"page":"e32922","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic status indicators and influencing factors in non-obese, non-centrally obese nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"102","author":[{"given":"Zhipeng","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, School of Inspection and Prevention, Quanzhou Medical College, Quanzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenji","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Radiology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3107-0621","authenticated-orcid":false,"given":"Jianjia","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/17474124.2018.1503947","article-title":"Health benefits of Mediterranean diet in nonalcoholic fatty liver disease.","volume":"12","author":"Abenavoli","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.3390\/nu14245335","article-title":"Diet and risk of non-alcoholic fatty liver disease, cirrhosis, and liver cancer: a large prospective cohort study in UK Biobank.","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients"},{"key":"R3-20250504","first-page":"1","article-title":"Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity.","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease.","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia.","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD.","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hbpd.2018.01.007","article-title":"Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: either non-obese or obese Chinese population.","volume":"17","author":"Lee","year":"2018","journal-title":"Hepatob Pancreat Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/jgh.14585","article-title":"Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: not uncommon and not always benign.","volume":"34","author":"Tobari","year":"2019","journal-title":"J Gastroen Hepatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3389\/fphys.2020.00542","article-title":"Critical roles of ELVOL4 and IL-33 in the progression of obesity-related cardiomyopathy via integrated bioinformatics analysis.","volume":"11","author":"Tao","year":"2020","journal-title":"Front Physiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fped.2018.00416","article-title":"Novel ultrasonographic fatty liver indicator can predict hepatitis in children with non-alcoholic fatty liver disease.","volume":"6","author":"Liu","year":"2019","journal-title":"Front Pediatr"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jfma.2019.03.014","article-title":"Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis.","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"871697","DOI":"10.3389\/fnut.2022.871697","article-title":"Assessing visceral obesity and abdominal adipose tissue distribution in healthy populations based on computed tomography: a large multicenter cross-sectional study.","volume":"9","author":"Kong","year":"2022","journal-title":"Front Nutr"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12902-020-00582-9","article-title":"Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): a United Kingdom population-based cohort study using the health improvement network (THIN).","volume":"20","author":"Vusirikala","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"R14-20250504","first-page":"713","article-title":"Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health.","volume":"5","author":"Eslam","year":"2020","journal-title":"Lancet Gastroenterol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment.","volume":"33","author":"Wong","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1253\/circj.66.987","article-title":"New criteria for \u201cobesity disease\u201d in Japan.","volume":"66","year":"2002","journal-title":"Circ J"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"823262","DOI":"10.3389\/fcimb.2021.823262","article-title":"Gut microbiome alterations in patients with visceral obesity based on quantitative computed tomography.","volume":"11","author":"Yan","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10388-021-00859-5","article-title":"Visceral fat obesity is the key risk factor for the development of reflux erosive esophagitis in 40-69-years subjects.","volume":"18","author":"Ohashi","year":"2021","journal-title":"Esophagus"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000507817","article-title":"Altered gene expression profiles in peripheral blood mononuclear cells in obese subjects.","volume":"13","author":"Jang","year":"2020","journal-title":"Obes Facts"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1756284819879047","DOI":"10.1177\/1756284819879047","article-title":"Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction.","volume":"12","author":"Ye","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3803\/EnM.2020.35.2.416","article-title":"Association of body mass index with the risk of incident type 2 diabetes, cardiovascular disease, and all-cause mortality: a community-based prospective study.","volume":"35","author":"Bae","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"560103","DOI":"10.3389\/fendo.2020.560103","article-title":"Effect of the interaction between pre-pregnancy body mass index and fresh\/frozen embryo transfer on perinatal outcomes of assisted reproductive technology-conceived singletons: a retrospective cohort study.","volume":"11","author":"Qu","year":"2020","journal-title":"Front Endocrinol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1111\/jgh.15544","article-title":"Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat.","volume":"36","author":"Chen","year":"2021","journal-title":"J Gastroen Hepatol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.metabol.2013.04.002","article-title":"Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean national health and nutrition examination survey.","volume":"62","author":"Hong","year":"2013","journal-title":"Metabolism"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.hbpd.2020.02.010","article-title":"Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese.","volume":"19","author":"Wu","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/HJH.0000000000002430","article-title":"Heritability and genetic correlations of obesity indices with ambulatory and office beat-to-beat blood pressure in the Oman Family Study.","volume":"38","author":"Man","year":"2020","journal-title":"J Hypertens"},{"key":"R27-20250504","first-page":"195","article-title":"Guidelines of prevention and treatment for non-alcoholic fatty liver disease: a 2018 update","volume":"26","author":"Fan","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12986-018-0316-5","article-title":"Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations.","volume":"15","author":"Maltais-Payette","year":"2018","journal-title":"Nutr Metab (Lond)"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1118\/1.3276776","article-title":"The use of PET images for radiotherapy treatment planning: an error analysis using radiobiological endpoints.","volume":"37","author":"Perrin","year":"2010","journal-title":"Med Phys"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.numecd.2019.01.016","article-title":"Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.","volume":"29","author":"Sung","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.je.2017.03.001","article-title":"Prevalence of abdominal obesity among Chinese adults in 2011.","volume":"27","author":"Du","year":"2017","journal-title":"J Epidemiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/liv.13993","article-title":"Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood.","volume":"39","author":"Cuthbertson","year":"2019","journal-title":"Liver Int"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5009\/gnl210084","article-title":"Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease.","volume":"16","author":"Kim","year":"2022","journal-title":"Gut Liver"},{"key":"R34-20250504","first-page":"801","article-title":"Clinical and laboratory characteristics of normal weight and obese individuals with non-alcoholic fatty liver disease.","volume":"12","author":"Trifan","year":"2022","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12906-021-03351-w","article-title":"The effect of apple cider vinegar on lipid profiles and glycemic parameters: a systematic review and meta-analysis of randomized clinical trials.","volume":"21","author":"Hadi","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"154911","DOI":"10.1016\/j.metabol.2021.154911","article-title":"Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.","volume":"126","author":"Tan","year":"2022","journal-title":"Metabolism"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"744710","DOI":"10.3389\/fendo.2021.744710","article-title":"The prevalence, popular trends, and associated and predictive factors of non-obese fatty liver disease.","volume":"12","author":"Deng","year":"2021","journal-title":"Front Endocrinol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study.","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2019.09.002","article-title":"Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: the impact of uric acid.","volume":"44","author":"Eshraghian","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","article-title":"Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.","volume":"69","author":"Wong","year":"2018","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T23:01:12Z","timestamp":1746313272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032922","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}